Meeting
2019 ASCO Annual Meeting
ONC201 in previously-irradiated pediatric H3 K27M-mutant glioma.
Authors
Sharon L. Gardner
NYU Langone Medical Center and School of Medicine, New York, NY
Sharon L. Gardner , Jeffrey C. Allen , Wafik Tharwat Zaky , Yazmin Odia , Doured Daghistani , Ziad Khatib , Carl Johannes Koschmann , Dolly Aguilera , Tobey J. MacDonald , Andrew S. Chi , Rohinton Tarapore , Krystal Merdinger , Wolfgang Oster , Joshua E. Allen , Soumen Khatua
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Clinical Trial Registration Number
NCT03416530
Citation
J Clin Oncol 37, 2019 (suppl; abstr 10046)
DOI
10.1200/JCO.2019.37.15_suppl.10046
Abstract #
10046
Poster Bd #
428
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.
First Author: Sharon L. Gardner
Poster
2020 ASCO Virtual Scientific Program
Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma.
First Author: Sylvia Christine Kurz
Poster
2020 ASCO Virtual Scientific Program
Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma.
First Author: Isabel Arrillaga-Romany
Poster
2020 ASCO Virtual Scientific Program
Clinical efficacy of ONC201 in thalamic H3 K27M-mutant glioma.
First Author: Abed Rahman Kawakibi